Olszewski AJ, Eradat HA, Avigdor A, Horowitz NA, et al. Mosunetuzumab and Polatuzumab Vedotin as First-line Treatment for Large B Cell
Lymphoma in Older Unfit or Frail Patients. Blood 2026 Oct 5:blood.2026035116. doi: 10.1182/blood.2026035116.
PMID: 42832423
|